Jason Konner, MD, is the Co‑founder of Psychedelic Oncology, an initiative exploring the intersection of psychedelic‑assisted healing and cancer care. As a medical oncologist, he spent over two decades treating patients at Memorial Sloan Kettering Cancer Center. Dr. Konner integrates relational and existential support into oncology to expand clinicians' understanding of how these therapies might ease existential distress in people facing serious illness.
Cancer care is not just about fighting the disease — it's about addressing the profound emotional and existential challenges patients face. How can healthcare providers support patients' mental and emotional needs while navigating these difficult journeys?
According to psychedelic oncologist Dr. Jason Konner, psychedelics, particularly psilocybin, can offer profound emotional relief to cancer patients by helping them address existential distress — something often overlooked in traditional oncology care. He emphasizes the importance of self-care for healthcare providers, suggesting that personal experiences with psychedelics can help combat burnout and improve the quality of care. By focusing on emotional and spiritual healing, doctors can support their patients through difficult diagnoses.
In this episode of Living Medicine, Dr. Sandy Newes sits down with Jason Konner, MD, Co-founder of Psychedelic Oncology, to discuss the intersection of oncology and psychedelics. Dr. Konner explains how psychedelics help cancer patients confront existential fears, the need for psychedelic literacy among healthcare providers, and how providers can avoid burnout through personal healing practices.
